USPTO 2015–2025 USPTO PatentsView US Corporation

Revive Solutions, Inc.

USPTO PatentsView assignee record - 6 granted patents across 2 technology areas, recorded in grant years 2018–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

RSS updates for this company

The verdict

According to USPTO PatentsView, Revive ranks #42,657 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 2 technology areas.

#42,657
of 49,997 US assignees by volume
8th percentile
by Innovation Score (21.2/100)
15.8
avg claims per patent
-100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R42657 · US Corporation #42,657 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 6 grants
  • LOWER-Q #42,657/49,997
  • PHOTO-FINISH Revelle Aesthetics
  • CPC-NARROW A61N · 2 areas
  • INNOV-THIN 21.2/100
  • CLAIMS-RICH 15.8 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -100% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Revelle Aesthetics, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Revive’s 21.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Revive

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Revive's Innovation Score is 21.2/100 (8th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Revive?

Each dot is one of Revive’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Revive’s own 15.8 claims/patent is ABOVE the 8.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Revive vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 5.96.06.066.06.06.1 0510152025 Granted patents (volume) Avg claims / patent Revelle Aesthetics, Inc. - 6, 8.33Revelle AestheticsRevelution Technology, LLC - 6, 2.5Revelution Techno…Revise Products LLC - 6, 6.67Revise ProductsRevive Environmental Technology, LLC - 6, 17.67Revive Environmen…Revolo Biotherapeutics Limited - 6, 20.83Revolo Biotherape…Revolution Lighting Technologies, Inc. - 6, 14.83Revolution Lighti…Revolution Retail Systems LLC - 6, 6Revolution Retail…Rgenix, Inc. - 6, 18.33RgenixRevive Solutions, Inc. - 6, 15.83Revive Solutions
Revive vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Revive's grants concentrate

Revive Solutions, Inc. is a focused PatentsView assignee: 2 CPC subclasses with 66.7% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2018 (5 grants) versus a trough of 1 in 2019. By volume, Revive sits between Revelle Aesthetics, Inc. and Rgenix, Inc..

Who files at Revive's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Revive holds 6 patents at rank #42,677, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Revive

By rank, the assignees closest to #42,677 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Revive's primary technology class.

Revive's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

21 8th percentile higher than 8% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 20182019 1
USPTO utility patent grants by year · 2018–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
Revive Solutions, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 5 83.3%
2019 1 16.7%

Which technologies does Revive Solutions, Inc. patent most?

Top 2 of 2 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Revive Solutions, Inc.'s patent record in context - here's where to go next.

  • Revive Solutions, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 66.7% of its portfolio - see every assignee active in that class. Explore A61N
  • Ranked #42,657 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Revive Solutions, Inc. against Revelle Aesthetics, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 21.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.